Hoʻopiliʻia kēia mau lāʻau lapaʻau i nā maʻi maʻi
ʻO nā lāʻau olaola he mau lāʻau'alomo i hanaʻia mai nā molekile paʻakiki i hanaʻia me ka hoʻohanaʻana i nā microorganisms ola, nā mea kanu, a me nā pūnaewele holoholona. Hoʻonuiʻia nāʻano ola honua me ka hoʻohanaʻana i keʻenehana DNA hou. I kekahi manawa ua kapaʻia lākou heʻano biopharmaceuticals a iʻole nā lāʻau lapaʻau.
Ua hoʻololi ke olakino i ka hoʻomaluʻana i nā maʻi nui a me nā maʻi kūlohelohe a ua kiʻi i nā lāʻau laulā maʻamau āpau mai kahiʻoihana kūʻai. ʻO ka'ōlohelohe Rheumatoid, kekahi mau maʻi pīpī, a me ka maʻi diabetis kaʻoi aku o ka nui o nā hōʻailona olaola i hoʻolaʻaʻia. Ke hoʻololi nei nā meaola i nāʻano hana a nā kauka i nā kūlana maʻamau i hōʻeha i nā kānaka no nā makahiki.
Bio Bioics
ʻOiaiʻo nā lāʻau lapaʻau he mau mekini i synthesiʻia mai nā meaʻokoʻa'ē aʻe, eʻoi aku ka maʻalahi o kaʻoihana biologics ma muli o kā lākou hana hana maʻamau. Ma muli o kā lākou uku kiʻekiʻe, aia kahi koi nui no nā hōʻailona likeʻole o nā lāʻau lapaʻau,ʻo ia hoʻi nāʻumi i heluʻia ma lalo nei. ʻO kekahi mauʻoihana kālai lāʻau e lobbying no ke kuleana e hana i nāʻanoʻenehana. Eia naʻe, no ka paʻakikī o ka hanaʻana, aia kekahi mau manaʻo e pili ana i ka hiki ke hana i nā genena ma ka palekana a me ka hilinaʻi.
Top 10 Biologics
ʻO nā hua'ōlelo heʻumi i heluʻia ma lalo nei uaʻoi aku ka nui ma mua o ka ho'ākāka kālā o kahi "blockbuster" i kapa inoa i ka lāʻau i hanaʻia ma mua o $ 1 biliona i nā kūʻai makahiki.
I ka makahiki 2015, hoʻomaka nā kumu honua i ka hoʻokūkū mai nā biosimilars , aiʻole nā biogenerics, i ka manawa i hakuʻia aiʻo Rituximab e IDEC Pharmaceuticals ma lalo o ka inoa IDEC-C2B8 . [1] Ua hoʻopukaʻia ka palapala noi US i ka makahiki 1998 a hoʻopauʻia i ka makahiki 2015. Ua halaʻo Humira i ka pale patent i ka makahiki 2016 a e lilo anaʻo Remicade i kāna mau pale i 2018.
ʻO nā kiʻi ma lalo nei no nā lā hope loa i hāʻawiʻia no kēlā me kēia huahana.
01 Humira
Hōʻike:ʻO ke kīpona Rheumatoid, plaque psoriasis, maʻi o Crohn, ulitisrative colitis, sparkylitis ankylosing; nā'ākia psoriatic, polyeticular juvenile idiopathic arthritis
Ka mea i hana ai: AbbVie, a me nā Abbott Laboratories
Global Sales ma 2015: $ 14 biliona
Inoa inoa: Adalimumab
Kākoʻo lā: 2002
02 Hōʻike
Nń Kuhikuhi: O ka hawewe ole Rheumatoid, ka maʻi o Crohn, ka spondylitis ankylosing, ka psoriatic arthritis, plaque psoriasis, ulitisrative colitis
Mea hana: Johnson & Johnson / Merck & Co.
Global Sales ma 2015: $ 5.78 piliona
ʻO ka inoa inoa pūnaewele: Infliximab
Ke hoʻomaka lā: 1998
03 Rituxan
Hōʻike: Na lymphoma non-Hodgkins, maʻi leukemia lymphocytic mau loa,ʻo ka maʻi'ōmaʻomaʻo
Mea hana: Roche
Global Sales ma 2015: $ 7.32 piliona
Kapa inoa inoa: Ritimimab
Ke kūkāʻana i ka lā: 1997
04 Enbrel
Hōʻike: Rathicatoid arthritis, plaque psoriasis, psoriatic arthritis
Mea hana: Pfizer / Amgen
Global Sales i 2016: $ 23 biliona
Inoa inoa: Etanercept
Ke hoʻomaka lā: 1998
05 Lantus
Hōʻike: Diabetes
Mea Hana: Sanofi
Global Sales ma 2015: $ 6.98 bila
Ke inoa inoa: Insulin glangine [rDNA kumu] injection
Ke Likana Hōʻike: 2000
06 Avastin
Hōʻike: Nānā, pale,'ekepeke, kino liʻiliʻi liʻiliʻi, glioblastoma, maʻi maʻi'ōpiopio
Mea hana: Roche
Global Sales ma 2015: $ 6.95 piliona
Inoa inoa: Bevacizumab
Hoʻouka laha: 2004
07 Iuliana
Hōʻike: HER2 + maʻi kanulau
Mea hana: Roche
Global Sales ma 2015: $ 6.59 piliona
Kapa inoa inoa: Trastuzumab
Ke hoʻomaka lā: 1998
08 Neulasta
Mea hana: Amgen
Global Sales i 2016: $ 4.6 piliona
Kapa inoa inoa: Pegfilgrastim
Kākoʻo lā: 2002
09 Lucentis
Hōʻike: Ke kuhiʻana o macular i pili i ka makahiki
Mea hana: Roche, Novartis
Global Sales ma 2015: $ 4.2 biliona
Inoa inoa: Ranibizumab
Hoʻouka lā: 2006
10 Ke kauwela
Ke Kōmikeʻo Gemanyʻo Fraunhofer Institute no ka Inihana Hana Hana a me ka Biotechnohana IGB a me CinnaGen Kamupene Cloned Interferon beta-1a a mai ka makahiki 2006 ua kūʻaiʻia ka lāʻau lāʻau e like me CinnoVex, heʻano likeʻole ma Iran.
Hōʻike: Hua'ōlelo nui (MS)
Mea hana: Biogen Idec
Global Sales ma 2014: $ 3 biliona
ʻO ka inoa inoa: Interferon beta-1a
Kākoʻo lā: 1996